Out-licensing: VM202

Pharmalicensing.com

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

UTEK Corporation

Out-licensing

Out-licensing
View

VM202

Gene-therapy product combining pCK naked DNA vector with genetically engineered Hepatocyte Growth Factor gene

Mechanism of action

Initiates collateral blood vessel formation

Full description

VM202, a gene therapy product for use with peripheral and coronary artery disease, utilizes therapeutic angiogenesis as a therapeutic approach for the treatment of cardiovascular diseases.

Development status

Preclinical

Patent information

One patent issued in Korea and has numerous pending patents being reviewed in Europe, Japan, US, China, Brazil and Singapore with respect to VM202.

Type of business relationship sought

Intend to enter into a technology transfer transaction or licensing agreement with respect to VM202.

Licensing contact

Young-Kyun Jung
Researcher
Technology Business Center

Contact directly

Company details

Korea Health Industry Development Institute

KHIDI, provides various services on technology transfer. KHIDI will license and commercialise several technologies of KHIDI's client companies via collaboration with overseas partners.

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Vessel Delineation in Magnetic Resonance Angiographic Images

IMG-003 - ULTRASOUND - Ultrasonic Blood Volume Flow Rate Meter

IMG-001 - MAGNETIC RESONANCE -Sliding Thin Slab Acquisition of MRI Data for MRA- SLINKY

IMG-002 - ULTRASOUND -Computer Controlled Positive Displacement Pump for Physiological Blood Flow Simulation

Active Guidewire Visualization Device and System for MRI Guided Interventions

Related categories

Industry sector: Biotechnology / Gene therapy; Drug discovery / Genomics
Therapeutic target: Cardiovascular / Acute coronary syndromes / Coronary artery disease; Cardiovascular / Acute coronary syndromes / Coronary heart disease; Cardiovascular / Acute coronary syndromes / Ischaemic heart disease; Cardiovascular / Thrombotic disorders / Peripheral arterial disease; Cardiovascular / Thrombotic disorders / Peripheral vascular disease

Clients in focus...

Get the Flash Player to see this rotator.

BioTrinity

Press releases: Pharmalicensing current industry press releases.

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd All rights reserved. Terms and Conditions | Contact us